These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35608794)

  • 1. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
    Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
    Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
    Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
    Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-promoting properties of
    Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
    Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
    [No Abstract]   [Full Text] [Related]  

  • 4. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Datta S; Timson DJ; Annapure US
    J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics analysis of potential functional metabolites in synbiotic ice cream made with probiotic Saccharomyces cerevisiae var. boulardii CNCM I-745 and prebiotic inulin.
    Zhou Z; Sarwar A; Xue R; Hu G; Wu J; Aziz T; Alasmari AF; Yang Z; Yang Z
    Food Chem; 2024 Oct; 454():139839. PubMed ID: 38810444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
    Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
    Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
    Chan MZA; Toh M; Liu SQ
    Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
    Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
    Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing L-fucose, a mammalian mucin component.
    Kim J; Cheong YE; Yu S; Jin YS; Kim KH
    Microb Cell Fact; 2022 Oct; 21(1):204. PubMed ID: 36207743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
    Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mutation in
    Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
    Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
    Sen S; Mansell TJ
    Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome Engineering Using Probiotic Yeast:
    Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
    Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
    Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
    Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
    Wombwell E; Bransteitter B; Gillen LR
    Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro digestion and characterization of selenized Saccharomyces cerevisiae, Pichia fermentans and probiotic Saccharomyces boulardii.
    Hyrslova I; Kana A; Nesporova V; Mrvikova I; Doulgeraki AI; Lampova B; Doskocil I; Musilova S; Kieliszek M; Krausova G
    J Trace Elem Med Biol; 2024 May; 83():127402. PubMed ID: 38310829
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
    ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of nutritional and physicochemical characteristics of soy yogurt by Lactobacillus plantarum KU985432 and Saccharomyces boulardii CNCMI-745.
    Mehaya FM; El-Shazly AI; El-Dein AN; Farid MA
    Sci Rep; 2023 Aug; 13(1):13026. PubMed ID: 37563274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Properties of Probiotic Saccharomyces boulardii Supernatant on Human Breast Cancer Cells.
    Pakbin B; Dibazar SP; Allahyari S; Javadi M; Amani Z; Farasat A; Darzi S
    Probiotics Antimicrob Proteins; 2022 Dec; 14(6):1130-1138. PubMed ID: 35094296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
    Poncelet A; Ruelle L; Konopnicki D; Miendje Deyi VY; Dauby N
    Infect Dis Now; 2021 May; 51(3):293-295. PubMed ID: 33934809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.